Now in its tenth year, the DIA/FDA Statistics 2016 Forum fosters open discussion of timely topics of mutual theoretical and practical interest to statisticians and clinical trialists who develop new drugs and biologics. This unique forum continues the dialogue on issues including guidance development and regulatory science initiatives.

Join 7000+ of your life sciences colleagues from industry, academia, regulatory and government agencies, health, patient, and philanthropic organizations for DIA 2016, and foster innovation that leads to the development of safe and effective products and therapies to patients. Hear about innovations and practical applications from industry and regulatory agency perspectives in the Statistical Science and Quantitative Thinking track, featuring sessions on pediatric clinical studies, open-label and long-term extension studies, futility analysis, biosimilars, adaptive designs, missing data, ADR information on labels, CMC, and the PCORnet Common Data Mode.

Just Announced: Keynote Speaker
Larry Brilliant, MD, MPH, acting Chairman of the Board of the Skoll Global Threats Fund, whose mission is to confront global threats such as Pandemics, Climate Change, Water, Nuclear Proliferation, and the Middle East Conflict.

Student Posters deadline just extended to March 31. Submit a Poster